Eu Yan Sang deepens net losses in Q4
EU Yan Sang deepened its losses for its fourth quarter ended June 30, 2016.
In its financial results released on Monday, it posted a net loss of S$14.1 million, from a net loss of S$3.6 million a year ago.
This was despite the traditional Chinese medicine group reporting a slight 2-per-cent increase in revenue to S$73.5 million, which was mostly due to higher wholesale revenue in Hong Kong.
The lower earnings was due to lower operating income (down 28 per cent to S$845,000), higher impairment loss on property, plant and equipment, intangible assets and other assets (of S$6.8 million versus S$417,000 a year ago) and a 94 per cent drop in fair value gain on investment properties to S$388,000.
For the higher impairment loss, the group said it was related to the writedown of the group's Australia business amounting to S$6.3 million due to difference between its carrying amount and value-in-use.
Other impairment losses include impairment of property plant and equipment of loss-making stores in Hong Kong amounting to S$145,000.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
Keppel prices 70 million euros of floating-rate notes due 2031
Mixed trading in Asia as investors watch for further macro data; STI down 0.2%
Shareholders raise questions over dividend payout, directors’ salaries at Best World AGM ahead of proposed privatisation
China’s Bank of Communications Q1 profit rises 1.44%
Huawei’s smart car tech offers automakers route to China sales
Electrolux Q1 loss nearly triples on weak demand but beats expectations